David Rickey, Director at CYTORI THERAPEUTICS, INC. (CYTX), bought 5,000 shares at $2.10 ($11K) on 2016-06-14, disclosed to the SEC on 2016-06-15.
Open-market purchase of $10k CYTX by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Nothing distinguishes this filing.
| Filing → |
| CYTX | BUY | 2015-08-28 | $23K | — | Filing → |
| CYTX | BUY | 2015-08-24 | $19K | — | Filing → |
| CYTX | BUY | 2015-08-20 | $19K | — | Filing → |